1993
DOI: 10.1001/archpedi.1993.02160310025011
|View full text |Cite
|
Sign up to set email alerts
|

Molecular-Clinical Correlations in Children and Adults With Fragile X Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
16
2
1

Year Published

1993
1993
2002
2002

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 18 publications
2
16
2
1
Order By: Relevance
“…We could not find cognitive differences between mosaic and full mutations, as other studies implied [Staley et al, 1993;Merenstein et al, 1996]. Still, no associations between any of the parameters analyzed and the lengths of the CGG repeat could be demonstrated.…”
Section: Discussioncontrasting
confidence: 75%
“…We could not find cognitive differences between mosaic and full mutations, as other studies implied [Staley et al, 1993;Merenstein et al, 1996]. Still, no associations between any of the parameters analyzed and the lengths of the CGG repeat could be demonstrated.…”
Section: Discussioncontrasting
confidence: 75%
“…Recent analysis with cytogenetic and DNA data indicates a significant positive correlation between high fragile X chromosome expression and large DNA alterations, i.e., increased number of CGG trinucleotide repeats (de Vries et al 1992, Staley et al 1992. Therefore, our fra(X) syndrome males with high expression probably have larger DNA alterations than those patients with low expression, even though our patients have not been analyzed at a molecular level.…”
Section: Discussionmentioning
confidence: 81%
“…Mosaic males (with both a full mutation and a premutation detected by Southern blot analysis) have been shown in some studies to have higher intellectual function and adaptive-skill development than males with a full mutation [Staley et al, 1993;Cohen et al, 1996;Merenstein et al, 1996], but this was not evident in other studies [de Vries et al, 1993;Rousseau et al, 1994a]. It is possible that a high proportion of cells with the premutation could influence clinical outcome, but this has not been demonstrated.…”
Section: Introductionmentioning
confidence: 98%